Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator - ScienceDirect
PPARγ as a therapeutic target in cystic fibrosis: Trends in Molecular Medicine
Molecular Therapies for Cystic Fibrosis - ScienceDirect
Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
Cystic fibrosis genetics: from molecular understanding to clinical application | Nature Reviews Genetics
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology
Frontiers | Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies | Pharmacology
Cystic fibrosis | Nature Reviews Disease Primers
Cystic Fibrosis
![PDF] Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/57c9fb781c9fad453067f30f86c222d279180a12/9-Figure3-1.png "PDF] Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. | Semantic Scholar")
PDF] Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. | Semantic Scholar
Progress in therapies for cystic fibrosis - The Lancet Respiratory Medicine
Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review)
Targeting ion channels in cystic fibrosis - Journal of Cystic Fibrosis
Cystic fibrosis - The Lancet
The different classes of CFTR gene mutations and the mechanisms of... | Download Scientific Diagram
Microbial infection in cystic fibrosis | British Society for Immunology
Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis | Gene Therapy
Structure of the cystic fibrosis transmembrane conductance regulator... | Download Scientific Diagram
Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function | Bentham Science
Frontiers | Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease | Pharmacology
Basics of the CFTR Protein | Cystic Fibrosis Foundation
Impaired Renal HCO3- Excretion in Cystic Fibrosis | American Society of Nephrology
Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota - Cellular and Molecular Gastroenterology and Hepatology
Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review)
JCM | Free Full-Text | An Intriguing Involvement of Mitochondria in Cystic Fibrosis | HTML
Cystic fibrosis transmembrane conductance regulator - Wikipedia
